Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Aptensio XR
(United States) [Available] ,Concerta
(United States) [Available] ,Daytrana
(United States) [Available] ,Methylin
(United States) [Available] ,Ritalin
(United States) [Available]Synonyms :
methylphenidate
Class :
ADHD Agents; Stimulants
Brand Name :
Aptensio XR
(United States) [Available] ,Concerta
(United States) [Available] ,Daytrana
(United States) [Available] ,Methylin
(United States) [Available] ,Ritalin
(United States) [Available]Synonyms :
methylphenidate
Class :
ADHD Agents; Stimulants
Dosage Forms & Strengths
Tablet
5mg
10mg
20mg
Capsule ER
10mg
15mg
20mg
25mg
30mg
50mg
55mg
60mg
70mg
85mg
Capsule ER/DR
20mg
80mg
60mg
100mg
Tablet ER
10mg
18mg
20mg
27mg
45mg
36mg
54mg
72mg
63mg
ER tablet, chewable
40mg
30mg
Tablet, chewable
5mg
2.5mg
10mg
oral solution
10mg/5mL
5mg/5mL
Dosage Forms & Strengths
Tablet
5mg
10mg
20mg
Capsule ER
10mg
15mg
20mg
25mg
30mg
50mg
55mg
60mg
70mg
85mg
Capsule ER/DR
20mg
80mg
60mg
100mg
Tablet ER
10mg
18mg
20mg
27mg
45mg
36mg
54mg
72mg
63mg
ER tablet, chewable
40mg
30mg
Tablet, chewable
5mg
2.5mg
10mg
oral solution
10mg/5mL
5mg/5mL
Refer adult dosing
CNS stimulants: they may increase the CNS depressant effect of antihistamines
CNS stimulants: they may increase the CNS depressant effect of antihistamines
CNS stimulants: they may increase the CNS depressant effect of antihistamines
CNS stimulants: they may increase the CNS depressant effect of antihistamines
dexchlorpheniramine, dextromethorphan, and phenylephrine
CNS stimulants: they may increase the CNS depressant effect of antihistamines
chlormethiazole: they may increase the CNS depressant effect of CNS stimulants
dexmedetomidine: they may increase the CNS depressant effect of CNS stimulants
lemborexant: they may increase the CNS stimulant effect of CNS stimulants
suvorexant: they may increase the CNS depressant effect of CNS Depressants
zolpidem: they may increase the CNS depressant effect of CNS Depressants
may increase the hypertensive effect of Inhalational Anesthetics
olopatadine: they may increase the CNS stimulant effect of CNS stimulants
flunarizine: they may increase the CNS depressant effect of CNS Depressants
kratom: they may increase the CNS depressant effect of CNS Depressants
clonidine may cause sudden or instant death with methylphenidate
it decreases the efficacy of antihypertensive agents
it decreases the efficacy of antihypertensive agents
it decreases the efficacy of antihypertensive agents
it decreases the efficacy of antihypertensive agents
it decreases the efficacy of antihypertensive agents
may have an increased cardiotoxic effect when combined with quinolones
may have an increased cardiotoxic effect when combined with quinolones
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
methylphenidate: they may decrease the antihypertensive effect when combined with antihypertensive drugs
methylphenidate: they may diminish the serum concentration of CYP3A4 Inducers
methylphenidate: they may diminish the serum concentration of CYP3A4 Inducers
methylphenidate: they may diminish the serum concentration of CYP3A4 Inducers
methylphenidate: they may diminish the serum concentration of CYP3A4 Inducers
methylphenidate: they may diminish the serum concentration of CYP3A4 Inducers
methylphenidate: they may increase the CNS depressant effect of CNS Depressants
methylphenidate: they may increase the CNS depressant effect of CNS Depressants
methylphenidate: they may increase the CNS depressant effect of CNS Depressants
methylphenidate: they may increase the CNS depressant effect of CNS Depressants
methylphenidate: they may increase the CNS depressant effect of CNS Depressants
it increases the cardiac toxicity of quinolones
may increase the cardiotoxic effect
Actions and Spectrum:
Action:
Spectrum:
Frequency defined
>10%
Decreased appetite (11%)
Insomnia (16%)
Decreased appetite (35%)
Affect lability (13%)
Upper abdominal pain (15%)
Nausea or vomiting (13%)
Decreased appetite (20%)
Decreased weight (12%)
Headache (10.9%)
Decreased appetite (25.3%)
Dry mouth (14%)
Headache (22.2%)
Nausea (12.8%)
Any insomnia (33%)
Insomnia (12.3%)
Decreased appetite (19%)
1-10%
Initial insomnia (6%)
Diarrhea (4%)
Nausea (6%)
Dry mouth (9%)
Feeling jittery (4%)
Headache (4%)
Decreased weight (4%)
Fatigue (3%)
Upper respiratory tract infection (2%)
Irritability (2%)
Nausea (2%)
Dysmenorrhea (2%)
Pregnancy consideration:
AU TGA pregnancy category: D
US FDA pregnancy category: Not assigned
Lactation: Excretion of the drug in human breast milk is known
Pregnancy category:
Category A:Â well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D:Â adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient information leaflet
Generic Name: methylphenidate
Why do we use methylphenidate?
methylphenidate is used for several purposes due to its stimulant properties and effects on neurotransmitter levels in the brain. Here are the main reasons why methylphenidate is commonly used:
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
